
News provided by Neurocrine Biosciences, Inc. Dec 02, 2022, 08:30 ET SAN DIEGO, Dec. 2, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today reported demographic and clinical characteristics […]